IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

With pharmaceutical companies heavily investing in R&D and precision medicine, the demand for high-quality specialty APIs is ...

The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

According to Grand View Research, the European and Middle Eastern drug screening markets are projected to grow significantly by 2030, with Europe expected to reach $3.6 billion and the Middle East and ...

Neither regulators nor police have attacked illegal production, promotion, and sale with sufficient vigor, perhaps because ...

It turns out that the anti-obesity space isn't growing as fast as Eli Lilly or analysts anticipated, resulting in ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

AbbVie forecast 2025 profit above estimates on Friday, as strong sales of its newer immunology drugs Skyrizi and Rinvoq make up for a steep decline in those of Humira, its flagship rheumatoid ...

My research colleague, John Bleday, and I have spent a lot of our time looking for great companies. How has the translated ...